On-label (n=496) | Off-label (n=713) | p Value | |
---|---|---|---|
Age (years), mean±SD | 65.32±10.41 | 66.0±9.93 | 0.252 |
Sex (male) | 341 (68.8) | 478 (67.0) | 0.532 |
Risk factors | |||
Diabetes | 136 (27.4) | 193 (27.1) | 0.904 |
Hypertension | 317 (63.9) | 474 (66.5) | 0.338 |
Hyperlipidaemia | 141 (28.4) | 177 (24.8) | 0.166 |
Current smoking | 83 (16.7) | 118 (16.5) | 0.941 |
History | |||
Stroke | 26 (5.2) | 37 (5.2) | 0.968 |
Previous MI | 114 (23.0) | 177 (24.8) | 0.461 |
Previous PCI | 65 (13.1) | 117 (16.4) | 0.114 |
Previous CABG | 3 (0.6) | 44 (6.2) | <0.001 |
LVEF, mean±SD | 41.97±23.69 | 42.92±23.47 | 0.657 |
Target vessel | |||
LAD | 249 (50.2) | 356 (49.9) | |
LCX | 120 (24.2) | 111 (15.6) | |
RCA | 127 (25.6) | 178 (25.0) | |
LM | 0 (0) | 45 (6.3) | |
SVG | 0 (0) | 23 (3.2) | |
Type of stent | 0.055 | ||
SES | 431 (86.9) | 592 (83.0) | |
PES | 65 (13.1) | 121 (17.0) | |
Stent length (mm), mean±SD | 22.05±5.40 | 39.77±17.47 | <0.001 |
Multivessel PCI | 205 (41.3) | 327 (45.9) | 0.128 |
Off-label indications | |||
Lesion length >30 mm | 551 (77.3) | ||
Bifurcation | 191 (26.8) | ||
Ostial lesion | 67 (9.4) | ||
Total occlusion | 67 (9.4) | ||
Lesion in LM | 45 (6.3) | ||
Reference-vessel diameter | |||
<2.5 mm | 15 (2.1) | ||
>3.75 mm | 59 (8.3) | ||
Restenotic lesion | 32 (4.5) | ||
Graft lesion | 23 (3.2) | ||
Angiographic success | 493 (99.4) | 702 (98.5) | 0.712 |
Results are shown as number (%) unless stated otherwise.
CABG, coronary-artery bypass grafting; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main stem; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention; PES, paclitaxel-eluting stent; RCA, right coronary artery; SES, sirolimus-eluting stent; SVG, saphenous vein graft.